Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
about
The potential role of behavioral therapies in the management of centrally mediated abdominal painSystematic review of randomized controlled trials: fiber supplements for abdominal pain-related functional gastrointestinal disorders in childhood.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.Cognitive-behavioral therapy for the management of irritable bowel syndromeStress reactivity in traditional Chinese medicine-based subgroups of patients with irritable bowel syndrome.Probiotics use to treat irritable bowel syndrome.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.The safety of novel drugs used to treat irritable bowel syndrome.Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.IgG-based elimination diet in migraine plus irritable bowel syndrome.Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile.Therapeutic Potential of Zataria multiflora Boiss in Treatment of Irritable Bowel Syndrome (IBS).
P2860
Q26859047-7866273A-3E7A-4CD5-B642-97933353D30BQ31084036-0F3C078F-6480-4C9A-9671-B80AA656E703Q34323319-D275139E-46C3-4657-B7FE-33343DDF720CQ36203967-66FA63D1-6F95-40C2-9A34-F22C18EFE34DQ37408834-16FF2FDA-160D-4380-B608-5E0926EB2EA2Q37715490-443EDFEA-6883-4365-8282-9A8081619DA6Q38035021-9F39500F-7BF9-4B01-AC0D-2014891D4A6CQ38175457-4336DDA0-BE08-4176-A348-5593D40AA421Q38199522-A3F6A5E0-C465-4EF8-98FE-AE7F05763833Q39401436-49B3B1F1-1DB7-456B-80C0-0B313CD00204Q43331702-8773EBFD-916A-4C21-97E1-4D4FF87D6A82Q43336624-59D0AF99-D063-4984-B8E3-B347D326D291Q44751762-BF6760A7-EAFC-43D7-8559-7A8EE8331067Q46319853-CD472AFF-1CCA-4E97-9F57-D66E43A7DABDQ48244839-BBA2FC28-C697-4968-BD2B-1C84342168F5
P2860
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@ast
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en-gb
type
label
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@ast
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en-gb
prefLabel
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@ast
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en-gb
P2860
P356
P1476
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.
@en
P2093
Anita Sainsbury
P2860
P304
P356
10.1177/1756283X10387203
P577
2011-03-01T00:00:00Z